JSE Developments Signal Recovery and Strategic Repositioning

  • Developments across the Jamaica Stock Exchange this week highlighted notable updates. Indies Pharma Jamaica Limited reported a strong third-quarter earnings recovery, Kintyre Holdings (JA) Limited strengthened its Board to support its growth strategy, and Sygnus Credit Investments Limited renewed its focus on shareholder value through a second share-buyback programme
  • Leading the week’s earnings releases, Indies Pharma Jamaica Limited reported improved results for the third quarter ended July 31, 2026. Revenue increased 12.4% year-over-year to J$292.38Mn, while net profit rose 25.1% to J$38.51Mn. Consequently, earnings per share increased to J$0.029 from J$0.023 in the corresponding period.
  • However, the nine-month results presented a more subdued picture, reflecting the disruption caused by Hurricane Melissa earlier in the financial year. Revenue was broadly unchanged, increasing 0.14% to J$857.10Mn, while net profit declined 28.5% to J$120.50Mn. Profitability was also constrained by higher finance costs following the refinancing of the company’s J$805Mn bond with a new J$1.00Bn facility. The quarterly rebound is encouraging, but a sustained earnings recovery will depend on continued revenue and earnings growth and the company’s ability to absorb its higher debt-servicing costs.
  • Turning to corporate governance, Kintyre Holdings (JA) Limited announced the appointment of three directors as the company enters what Chairman and CEO Tyrone Wilson described as its next phase of growth. The appointments appear strategically aligned with the Group’s need to strengthen oversight while supporting its expansion plans.
  • Jahmar Clarke brings corporate and commercial law expertise to the HR & Compensation Committee. Christopher "Chris" Denny, a 20-year banking and capital markets veteran from Citigroup and FirstCaribbean, steps in as Audit Committee Chair to strengthen financial reporting and controls. Finally, Neil Patrick, formerly of Digicel and Orange UK, joins the Audit and Compensation Committees while also working directly with the Group to build out its technology division. Collectively, the appointments combine stronger legal, financial and governance oversight with expertise that could support Kintyre’s technology-led growth ambitions.
  • Rounding out the week, Sygnus Credit Investments Limited unveiled a second Share Buyback Programme, at a time when its shares continue to trade significantly below net asset value (NAV). It is authorising up to US$4.5Mn in repurchases of its JMD and USD Ordinary Shares through June 2029. The programme extends SCI’s existing capital-management strategy. Under its first programme, which ran from June 2023 to June 2026, the company repurchased 136,525 USD shares and approximately 10.30Mn JMD shares. The renewed authorisation gives SCI the flexibility to repurchase shares when they trade below net asset value, potentially narrowing the discount and supporting shareholder value. However, the ultimate benefit will depend on the timing and pricing of the repurchases relative to the company’s other capital-deployment opportunities.

(Sources: JSE, NCBCM Research)